Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Cullinan Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Cambridge, MA, United States

  1. PrincipalsCorrine SavillChief Business OfficerJacquelyn L SumerChief Legal OfficerJeffrey Alan JonesChief Medical Officerand 3 more
  2. CompanyCullinan Therapeutics, Inc.Cambridge, MA, United States
  3. Phone line+1 (617) 410-4650General business
Request a quote

Cullinan Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker CGEM) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 6

Chief executive

Nadim AhmedPresident and CEO

Finance

Mary Kay FentonChief Financial Officer

Legal

Jacquelyn L SumerChief Legal Officer
Everyone else on file (3)
Corrine SavillChief Business Officer
Jeffrey Alan JonesChief Medical Officer
Jennifer MichaelsonChief Scientific Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Jennifer Michaelson — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Jacquelyn L Sumer — Chief Legal Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Jeffrey Alan Jones — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Corrine Savill — Chief Business Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers